Shire plc, each representing three Ordinary Shares (SHPG): M&A News

SHPG – Shire plc acquisition by Takeda receives unconditional clearance from the FTC.


Key Facts Surrounding This News Item


  • SHPG had a POWR Rating of A (Strong Buy) coming into today.
  • SHPG was 2.47% above its 10-Day Moving Average coming into today.
  • SHPG was 4.42% above its 20-Day Moving Average coming into today.
  • SHPG was 4.48% above its 50-Day Moving Average coming into today.
  • SHPG was 12.40% above its 100-Day Moving Average coming into today.
  • SHPG was 14.69% above its 200-Day Moving Average coming into today.
  • SHPG had returned +11.15% year-to-date leading up to today’s news, versus a +5.02% return from the benchmark S&P 500 during the same period.

More Info About Shire plc, each representing three Ordinary Shares (SHPG)


Shire plc is engaged in developing and marketing medicines for patients with rare diseases and other specialty conditions. The Company commercializes its products in the areas of Neuroscience, Gastrointestinal, rare diseases and other therapeutic areas. The company was founded in 1986 and is based in Dublin, Ireland. View our full SHPG ticker page with ratings, news, and more.

SHPG at a Glance

SHPG Current POWR Rating™
Overall POWR Rating™
SHPG Current Price $166.22 2.27%
More SHPG Ratings, Data, and News

SHPG Price Reaction

The day of this event (Jul. 10, 2018)
SHPG Closing Price$172.87 1.04%
SHPG Volume992,076
23.79% from avg
Leading up to this event
SHPG 1-mo returnN/A%
After this event
SHPG 1-day return0.49%
SHPG 3-day return0.94%
SHPG 5-day return0.74%

SHPG Price Chart


The Top Stocks For 2019

More Shire plc, each representing three Ordinary Shares (SHPG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SHPG News
Page generated in 0.8533 seconds.